2/10 · Low — ~6% forward EPS CAGR from a rate-base grind; fully regulated, no acceleration, no multibagger path
Technicals
Rangebound — $47.88, −4.8% off 52-wk high, hovering around 50/200-DMA, RSI 67, +10% 12-mo (SPY +21%)
Conviction
None — 0 expert voices, 0 traceable claims in the Synthos KB; verdict rests on fundamentals + quant
Position sizing
Income/defensive sleeve only, 0–2%; not a flagship growth holding
Next catalyst
2026-07-30 Q2'26 earnings (Street EPS $0.48)
Single biggest risk
Rate-case / regulatory outcomes and rising interest cost on a highly levered balance sheet (5.6× net-debt/EBITDA)
One-line thesis. Exelon is a pure-play, fully-regulated transmission-and-distribution (T&D) utility across six utilities in the mid-Atlantic and Illinois — a low-beta, dividend-paying bond-proxy that earns a regulated return on a growing rate base, grows EPS ~6%/yr, and trades right on top of both Street consensus and our own fair value, which is why it lands a Watch, not a Buy.
◆ Synthos call — HoldEXC is a solid business largely reflected at ~$49 — fine to keep, no reason to chase; it gets interesting again below ~$42.
Downside Risk (lower = safer)
5/10 · Moderate
Low beta (0.41) & regulated cash flows offset by 5.6× net-debt/EBITDA and chronic negative FCF.
Fully regulated T&D utility; growth is decelerating rate-base grind, no acceleration, no room to multibag.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 7%/yrTo justify today’s $48, earnings would have to compound roughly 7% a year for 10 years (9% discount rate). Analysts forecast ~6%/yr, so the market is pricing in about what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Exelon is the company that owns the power lines and the poles — the wires that deliver electricity to homes and businesses in Chicago, Baltimore, Philadelphia, and the Washington DC area. It does not own power plants anymore (it spun those off in 2022). It just runs the delivery grid, and government regulators set the profit it's allowed to earn. That makes it steady and boring — like a toll road for electricity.
Is the stock cheap or expensive? It's priced about right — trading almost exactly where Wall Street and our own math say it's worth. So there's no bargain here, but no obvious rip-off either. Our verdict is Watch: a fine, safe, dividend-paying stock to own for income, but not something that will make you rich, and not cheap enough right now to rush in.
Here's what our three scores mean in everyday terms:
Downside Risk 5/10 (middle). The stock barely moves and the cash flows are predictable, but the company carries a lot of debt, so higher interest rates and regulator decisions can pinch it.
Growth Quality 4/10 (below average). It grows slowly and steadily — think ~6% a year — and doesn't earn especially high returns. Reliable, not exciting.
Exponential Potential 2/10 (low). This is the opposite of a rocket ship. A regulated utility grows at a set pace by law; it can't suddenly double.
The one big worry: Exelon owes a large amount of money, and its profits depend on regulators approving rate increases. If interest costs rise faster than approved returns, or regulators say no, the earnings and the dividend get squeezed.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLU (sector)), set to 100 a year ago
Solid = EXC · dashed = S&P 500 · dotted = XLU (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$47.88
Market cap$49B
P/E trailing2×
P/E FY26E / FY27E17× / 16×
EV / Sales4.0×
EV / EBITDA11.1×
Gross margin24.1%
Net margin11.2%
Dividend yield3.43%
Beta0.41
52-wk range$43 – $50
RSI(14)67
50 / 200-DMA$46 / $46
12-mo return+10% (SPY +21%)
Street target$49 ($41–$55)
Analyst grades14 Buy · 21 Hold · 2 Sell
FMP ratingB+
Next earnings2026-08-05
What the experts actually said 0 traceable claims on EXC · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Exelon Corporation (Nasdaq: EXC) is a Chicago-based utility holding company. After spinning off its competitive generation and retail business (Constellation Energy) in February 2022, Exelon is now a pure-play, fully-regulated transmission and distribution utility — it owns the wires, poles, substations and pipes that deliver electricity and natural gas, and earns a regulator-approved return on that infrastructure ("rate base"). It does not own merchant power plants, so it has no direct commodity-price exposure to power or fuel. Fiscal year ends December 31. CEO: Calvin G. Butler Jr. ~20,000 employees.
Baltimore Gas & Electric (BGE, Maryland): $5.22B (22%)
PECO Energy (Pennsylvania): $4.68B (19%)
Delmarva Power & Light: $1.97B · Atlantic City Electric: $1.72B · Corporate/other $0.42B
(Note: FMP's segment table sums the sub-utilities to more than consolidated revenue because of Pepco Holdings/Atlantic City/Delmarva reporting overlap; treat the shares as directional. Consolidated FY25 revenue was $24.26B.)
By geography: effectively 100% United States (Illinois, Maryland, Pennsylvania, DC, New Jersey, Delaware). FMP reports no geographic segmentation — appropriate for a domestic-only utility. The concentration in Illinois (ComEd) and the mid-Atlantic makes state-level regulatory outcomes the dominant earnings driver.
The strategic story is simple and unglamorous: grow the regulated rate base (grid modernization, reliability, electrification, and — the topical upside — data-center / AI load growth in its territories), file rate cases to earn an allowed return on that base, and pay a growing dividend.
2. The expert thesis — why the panel is bullish (traceable)
There is no expert coverage of Exelon in the Synthos knowledge base.total_claims = 0, net_bullish_voices = 0, and the top list is empty. No independent voice in our panel has published a traceable claim on EXC, bullish or bearish.
This is normal and expected for a regulated utility: the expert panel skews toward technology, AI, biotech and high-growth secular themes, and regulated bond-proxies rarely draw commentary. Honesty is the product — so we say plainly: this verdict is 100% fundamentals- and quant-driven. There is no conviction score to report, no claim_id to cite, and none is fabricated. Every number below comes from the FMP financials, estimates, and price data.
If and when a tracked voice publishes a dated, traceable view on EXC (e.g., a utility-sector or rates/macro analyst), this note will be re-scored to reflect it.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
5 · Moderate
Beta 0.41 and fully-regulated cash flows make the equity low-volatility, but net-debt/EBITDA is 5.6× and FCF is chronically negative (capex > operating cash), so leverage and rate-case risk offset the defensiveness.
Growth Quality
4 · Below Average
~6% forward EPS CAGR, roughly flat real revenue, ROE 9.8%, ROIC ~3.9% — steady regulated compounding but pedestrian returns on a lot of capital.
Exponential Potential
2 · Low
A fully-regulated T&D utility grows at a legislated pace; growth is decelerating (revenue est. CAGR ~2–3%), there is no acceleration, and a $49B cap in a mature domestic market leaves no multibagger runway.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them.
Case
Key assumptions
Fair value
Bull
Data-center / electrification load accelerates rate-base growth; constructive rate-case outcomes; rates ease, lowering interest cost. FY27E EPS beats to ~$3.15 (vs $3.04 cons) and the multiple re-rates to ~18.5×.
~$58 (+21%)
Base(our anchor)
Estimates roughly hit — FY27E EPS $3.04; a low-growth regulated utility earns its historical ~16× forward multiple.
~$49 (+2%)
Bear
Adverse rate cases, higher-for-longer rates raise interest expense faster than allowed ROE, dividend growth slows. FY27E EPS misses to ~$2.85; multiple de-rates to ~14×.
~$40 (−16%)
Synthos fair value = the base case, ~$49 (+2%), with the full $40–$58 span as the honest range. This anchor sits essentially on top of the Street's $48.91 consensus — for a regulated utility whose earnings are set by a formula, that convergence is expected and is itself the finding: there is no valuation edge here. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). EXC is neither — it is a regulated rate-base grinder, and we score its Exponential Potential 2/10 (Low) honestly:
Forward growth: revenue CAGR FY25→FY30E ~3.0% ($24.3B → $28.2B); EPS CAGR ~6.3% ($2.74 → $3.71). The EPS growth exceeds revenue growth because the allowed return applies to a rising rate base, not because of operating leverage.
Acceleration (the 2nd derivative) is flat-to-negative: EPS growth runs ~+4–7% per year with no inflection — FY26E +4.3%, FY27E +6.3%, FY28E +7.2%, FY29E +6.2%, FY30E +7.3%. This is a legislated cadence, not a demand curve; there is no acceleration to capture.
Room to run: the one genuine upside vector is data-center / AI load growth in ComEd (Illinois) and BGE (Maryland/PJM) territories, which could lift rate-base growth above the historical ~7%. But even a strong version of that is a rate-of-grind story, not a step-change; at $49B in a mature, fully-regulated domestic market, a 3–5× is structurally impossible.
Reinvestment runway: capex is heavy and productive in the regulated sense (~$8.5B FY25, growing the rate base), but it is funded by debt and equity issuance — FCF is negative by design — so it compounds book value at the allowed ROE (~9–10%), not at exponential rates.
Exponential Potential: Low. Own EXC for a ~3.4% dividend and low-volatility regulated compounding — never for a multibagger. This is the honest opposite of a flagship next-exponential.
Revenue: FY25 $24.26B, +5.3% (FY24 $23.03B, +6.0% on FY23 $21.73B). Growth is modest and driven by rate increases and load, not volume expansion.
Quarterly trajectory: utility revenue is seasonal (summer/winter peaks). Q1'25 $6.71B → Q2 $5.43B → Q3 $6.71B → Q4 $5.41B → Q1'26 $7.24B (+7.9% YoY). Q1'26 EPS $0.90 (in line to slightly ahead).
Margins: gross 24.1% TTM, operating ~21.0%, net 11.2% TTM. EBITDA margin ~36% (typical for a capital-intensive regulated utility where depreciation is large).
Earnings: net income $2.77B FY25 (+12.5% on FY24 $2.46B); EPS $2.74 vs $2.45. A clean, steady progression.
Cash flow (the important tell): operating CF $6.25B FY25, capex −$8.53B → FCF −$2.28B. FCF has been negative every year shown (−$2.3B FY25, −$1.5B FY24, −$2.7B FY23) because rate-base growth requires capex above operating cash. The gap is plugged by debt and equity issuance — this is the utility model, but it means the dividend is not covered by free cash flow and depends on continued market access.
Balance sheet: total debt $50.6B, net debt $49.4B, net-debt/EBITDA 5.6× — high in absolute terms but standard for a regulated T&D utility (regulators allow it because cash flows are stable). Interest coverage is thin at ~2.4×, and interest expense rose to $2.13B FY25 from $1.91B FY24 — the clearest channel through which higher rates bite.
6. Valuation — priced in or room?
EXC trades at 17.5× trailing EPS, 4.0× sales, 11.1× EV/EBITDA, with a 3.4% dividend yield and a ~59% payout ratio. On forward estimates the multiple is 16.8× (FY26E) → 15.8× (FY27E) → 12.9× (FY30E) — a gentle compression as EPS grinds higher at a flat-to-slightly-lower price. For a regulated utility, the right frame is dividend yield + rate-base-driven EPS growth vs. the 10-year Treasury: at a 3.4% yield plus ~6% EPS growth, the total-return math is a high-single-digit bond-proxy, attractive only relative to where long rates sit. Street targets (context): consensus $48.91, high $55, low $41 — and our $49 base fair value is essentially identical. That is the finding: EXC is fairly valued, with no discount to exploit. Not cheap, not expensive — a hold-for-income valuation, not a buy-the-dip one.
7. Technicals (from the tech block)
Trend:neutral / rangebound. $47.88 sits just above the 50-DMA ($45.74) and 200-DMA ($46.01), with the two averages nearly on top of each other — no clear trend, consolidation. MACD +0.41 (mildly positive).
Location:−4.8% off the 52-week high ($50.29), +12.1% off the 52-week low ($42.73) — mid-range, shallow max drawdown (−4.8% from peak). The +3.5% move on the quote day is a single-session pop, not a breakout.
Momentum: RSI(14) 66.8 — approaching but not yet overbought (<70); no stretched-entry signal, but limited slack.
Relative strength (the tell): EXC +10.3% 12-mo vs SPY +20.6% and QQQ +30.3%; and −2.0% over 3 months while SPY +13.7% / QQQ +22.0%. A textbook defensive laggard — it underperforms in risk-on tapes, which is exactly what a low-beta utility does.
Read: technicals are consistent with a bond-proxy: low volatility, rangebound, lagging the growth indices. No momentum reason to chase; the entry that matters is yield and rate-case news, not the chart.
8. Moat & competitive position
Exelon's "moat" is regulatory, not competitive: each of its six utilities is a legal monopoly in its service territory (you cannot choose a different wires company for your home), and returns are set by state regulators and FERC. There is no customer-acquisition battle and no direct competitor for the pipes — the flip side is that the ceiling on returns is also set by regulators (allowed ROE ~9–10%). So the durability is high but the upside is capped by design. The real "competition" is for capital: EXC competes with every other utility for investor dollars, and its relative attractiveness is a function of rate-base growth, regulatory constructiveness, and balance-sheet quality.
Peer set (regulated utilities, market cap): NextEra $184B (the growth-utility benchmark), Southern $110B, Duke $101B, American Electric Power $75B, Dominion $61B, Entergy $53B, Consolidated Edison $42B, PSEG $41B, WEC $39B, plus smaller peers (CMS, CenterPoint, Edison Int'l, Evergy, FirstEnergy, Alliant, Pinnacle West, PPL). Within this group EXC is a large, pure-T&D play (no generation risk) — lower-risk than integrated peers but also with less renewables-growth optionality than a NextEra.
9. Management, capital allocation & guidance
Capital allocation: the entire model is rate-base reinvestment — ~$8.5B/yr capex growing the regulated asset base, funded by a mix of debt (net +$3.5B FY25) and modest equity issuance (+$0.73B FY25), with a growing dividend ($1.64/yr, ~$1.62B paid FY25, ~59% payout). No buybacks — appropriate, since the utility model reinvests to grow rate base rather than shrink the share count. The tension to watch: equity issuance dilutes per-share growth, and rising debt raises interest cost.
Insider activity: the sampled window (2026-04 to 2026-07) shows only routine director equity awards — restricted stock units and deferred phantom shares granted to board members (Rogers, Lillie, Cheshire, Bowers, Segedi, Richo). These are compensation grants at $0 cost, not open-market buys or sells, and carry no signal. No alarming discretionary selling in the window.
Guidance: management's forward framework is the standard utility construct — a multi-year EPS growth target and rate-base CAGR (historically framed around ~5–7% EPS growth), consistent with the analyst-estimate trajectory used here. Gap flagged: no dated management guidance claim is ingested into the Synthos KB for EXC; the forward figures above are analyst consensus (FMP), labeled as estimates.
10. Catalysts & what to watch
Next earnings: 2026-07-30 (Q2'26; Street EPS $0.48, revenue ~$5.40B). Q2 is a seasonally lighter quarter; the key line is rate-case progress and capital-plan updates, not the print.
Rate cases: outcomes at ComEd (Illinois), BGE (Maryland), PECO (Pennsylvania) and Pepco (DC/Maryland) — allowed ROE and rate-base decisions are the single biggest earnings driver.
Data-center / AI load growth: interconnection and load-forecast updates in the PJM footprint (ComEd, BGE) — the one credible above-trend growth vector.
Interest-rate path: as a levered bond-proxy, EXC's total return and interest expense are highly sensitive to the 10-year Treasury; a rate-cutting cycle is a tailwind, higher-for-longer a headwind.
Dividend action: the annual dividend increase and any change to the target payout/growth rate.
Thesis tripwires (what would change the call): a materially adverse rate-case ruling; interest expense rising faster than allowed ROE (margin squeeze); a dividend-growth cut; or, on the upside, a step-change in data-center load commitments that lifts the rate-base CAGR — that last one would push us to revisit the Watch.
11. Key risks
Regulatory (structural): earnings are set by state regulators and FERC; an adverse rate case or lower allowed ROE directly cuts earnings. This is the dominant risk for any regulated utility.
Leverage & rates: net-debt/EBITDA 5.6× with ~2.4× interest coverage — higher-for-longer rates raise interest expense (already $2.13B FY25) and compress the equity value of a bond-proxy.
Negative free cash flow / funding dependence: FCF has been negative every year; the dividend and capex plan depend on continued access to debt and equity markets on reasonable terms.
Equity dilution: ongoing share issuance to fund capex dilutes per-share growth (shares out ~1.01B and rising).
Growth is capped: no path to above-utility growth absent a data-center surprise; a risk-on market will keep leaving it behind (as the 1-yr relative underperformance shows).
No expert coverage: the Synthos KB has zero traceable claims on EXC, so there is no independent-analyst signal to corroborate or challenge the quant read — the verdict leans entirely on fundamentals.
12. Verdict, position sizing & monitoring
Watch. Exelon is a well-run, fully-regulated T&D utility — low beta (0.41), a ~3.4% dividend, steady ~6% EPS growth, and no commodity risk. It is also fairly valued (our $49 base fair value sits right on the $48.91 Street consensus), carries high leverage (5.6× net-debt/EBITDA), generates negative free cash flow by design, and has no expert conviction behind it in our KB. None of that is a reason to sell; all of it is a reason not to reach for it as a growth holding. It is a bond-proxy trading at fair value — the definition of a Watch.
Sizing: if held at all, an income/defensive sleeve position, 0–2% — for the dividend and low volatility, not for appreciation. A better entry would be a discount to fair value (say, mid-$40s / ~4%+ yield) or a constructive rate-case / data-center-load catalyst.
Monitoring: re-underwrite on rate-case outcomes and the interest-expense trajectory; re-score if a tracked expert publishes on EXC or if data-center load materially lifts the rate-base plan. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $47.88.
Single biggest risk: adverse rate-case / regulatory outcomes combined with rising interest cost on a highly levered balance sheet.
Provenance & disclosures
Traceability: 0 KB claims, breadth 0 — no expert coverage in the Synthos KB. This note is explicitly fundamentals- and quant-driven; no claim_id is cited because none exists, and none is fabricated (claim-ID reconciliation makes fabricated conviction structurally impossible).
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03. Forward figures are analyst consensus (FMP), labeled as estimates.
Segment caveat: FMP's sub-utility segment revenues sum above consolidated revenue due to reporting overlap; treat mix shares as directional. Consolidated FY25 revenue $24.26B.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").